Published on 24 Dec 2021 on Zacks via Yahoo Finance
Integra LifeSciences Holdings Corporation IART is gaining from ongoing sales recovery across geographies and products. The company ended the third quarter of 2021 with better-than-expected results. Sales from the recently introduced CereLink ICP Monitor System buoy optimism.
However, foreign exchange fluctuation and stiff competition remain concerning.
Over the past year, the Zacks Rank #3 (Hold) stock has gained 3.1% compared with 9.8% growth of the industry. This compares to the 27% rise of the S&P 500.